Question 1

How can a specific interferon antagonist be identified in a viral genome?

Accepted Answer

Individual viral genes are expressed alone in reporter cells and screened for suppression of interferon induction or downstream signalling. Hits are then tested for dose dependence and confirmed in the infection context using a recombinant virus lacking that gene. Sequence similarity to known antagonists offers a starting point but never substitutes for direct functional evidence.

Question 2

Why are interferon reporter assays alone insufficient evidence?

Accepted Answer

Reporter output falls whenever transcription, translation or cell viability is impaired, so a viral protein that is simply toxic can mimic genuine antagonism. Orthogonal readouts such as phosphorylation of signalling kinases, nuclear localisation of transcription factors, and endogenous transcript measurement are needed before a mechanism can be assigned with confidence.

Question 3

What controls does a recombinant knockout virus require?

Accepted Answer

The parental strain grown in parallel is essential, along with a revertant or complemented virus that restores the gene. Replication should be compared in cells competent for interferon signalling and in cells lacking receptor or kinase function. If attenuation disappears in the signalling deficient line, the phenotype genuinely reflects immune evasion.

Question 4

How are direct binding partners of a viral antagonist established?

Accepted Answer

Co-immunoprecipitation from infected cells, followed by mass spectrometry, gives candidate partners; proximity labelling captures transient contacts that survive poorly through washing. Reciprocal pull downs and targeted point substitutions that abolish the interaction without destabilising the protein then distinguish a functional contact from incidental association.

Question 5

Which cell systems best reflect physiological interferon responses?

Accepted Answer

Primary cells and differentiated cultures retain sensing pathways that many immortalised lines have lost or dampened, and organoid or air liquid interface systems add tissue architecture. Common laboratory lines remain useful for mechanism because they are tractable, but conclusions about magnitude of suppression should be checked in a more physiological setting.

Question 6

How should cytokine measurement timing be planned?

Accepted Answer

Sampling must cover induction, peak and resolution rather than a single endpoint, because antagonists frequently delay rather than abolish output. Parallel transcript and secreted protein measurements separate transcriptional blockade from interference with secretion. Recording the multiplicity of infection alongside every timepoint keeps comparisons between strains meaningful.

Microbiology

Microbiology

Research Frontiers in Viral Immune Antagonism and Interferon Suppression